The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
41 | 35 | 43 | 55 |
Growth
|
7 | 11 | 31 | 7 |
Safety
|
67 | 83 | 75 | 97 |
Sentiment
|
26 | 83 | 45 | 94 |
|
14 | 59 | 43 | 79 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Analyst Opinions
|
100 | 97 | 87 | 97 |
Opinions Change
|
10 | 50 | 50 | 50 |
Pro Holdings
|
n/a | 50 | 25 | 92 |
Market Pulse
|
13 | 84 | 29 | 27 |
Sentiment
|
26 | 83 | 45 | 94 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
41 | 35 | 43 | 55 |
Growth
|
7 | 11 | 31 | 7 |
|
67 | 83 | 75 | 97 |
Combined
|
16 | 23 | 47 | 59 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Price vs. Sales (P/S)
|
58 | 42 | 50 | 50 |
Price vs. Earnings (P/E)
|
42 | 36 | 29 | 39 |
Price vs. Book (P/B)
|
10 | 10 | 14 | 43 |
Dividend Yield
|
74 | 67 | 76 | 82 |
Value
|
41 | 35 | 43 | 55 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue Growth
|
25 | 23 | 32 | 8 |
Profit Growth
|
14 | 12 | 59 | 32 |
Capital Growth
|
6 | 19 | 17 | 9 |
Stock Returns
|
23 | 47 | 83 | 25 |
Growth
|
7 | 11 | 31 | 7 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Leverage
|
80 | 84 | 82 | 92 |
Refinancing
|
20 | 32 | 32 | 48 |
Liquidity
|
89 | 90 | 88 | 92 |
|
67 | 83 | 75 | 97 |
Discover high‑ranked alternatives to Sanofi India and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.